GSA Capital Partners LLP Has $233,000 Holdings in Doximity, Inc. (NASDAQ:DOCS)

GSA Capital Partners LLP trimmed its stake in Doximity, Inc. (NASDAQ:DOCS) by 73.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,346 shares of the company’s stock after selling 14,641 shares during the period. GSA Capital Partners LLP’s holdings in Doximity were worth $233,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. William Blair Investment Management LLC grew its position in shares of Doximity by 15.8% in the 2nd quarter. William Blair Investment Management LLC now owns 6,404,068 shares of the company’s stock valued at $179,122,000 after buying an additional 873,682 shares during the last quarter. Clearbridge Investments LLC increased its position in Doximity by 7.1% during the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock valued at $163,709,000 after purchasing an additional 387,200 shares during the period. Swedbank AB bought a new position in Doximity during the 1st quarter worth approximately $91,673,000. Janus Henderson Group PLC lifted its position in shares of Doximity by 33.5% in the 1st quarter. Janus Henderson Group PLC now owns 2,474,695 shares of the company’s stock worth $66,594,000 after purchasing an additional 621,590 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in shares of Doximity by 23.1% in the 2nd quarter. Renaissance Technologies LLC now owns 1,603,202 shares of the company’s stock valued at $44,842,000 after purchasing an additional 301,100 shares during the last quarter. 87.19% of the stock is owned by institutional investors.

Doximity Price Performance

DOCS opened at $48.20 on Monday. The firm’s fifty day moving average price is $44.64 and its two-hundred day moving average price is $35.16. The company has a market capitalization of $9.00 billion, a price-to-earnings ratio of 55.40, a P/E/G ratio of 3.89 and a beta of 1.30. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $61.75.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on DOCS shares. Baird R W upgraded shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Morgan Stanley upgraded Doximity from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $33.00 to $53.00 in a research report on Thursday, November 14th. KeyCorp upgraded Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a report on Friday, November 8th. The Goldman Sachs Group assumed coverage on Doximity in a report on Friday, November 15th. They set a “neutral” rating and a $58.00 price target on the stock. Finally, Robert W. Baird lifted their price objective on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research note on Tuesday, September 17th. Eleven investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $52.27.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.